Literature DB >> 17289150

Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases.

Claire Gavériaux-Ruff1, Brigitte L Kieffer.   

Abstract

Conditional gene knockout represents an extremely powerful approach to study the function of single genes in the nervous system. The Cre-LoxP system is the most advanced technology for spatial and temporal control of genetic inactivation, and there is rapid progress using this methodology in neuroscience research. In this approach, mice with LoxP sites flanking the gene of interest (floxed mice) are bred with transgenic mice expressing Cre recombinase under the control of a selected promoter (Cre mice). This promoter is critical in that it determines the time and site of Cre expression. Cre enzyme, in turn, recombines the floxed gene and produces gene knockout. Here we review Cre mouse lines that have been developed to target either the entire brain, selected brain areas, or specific neuronal populations. We then summarize phenotypic consequences of conditional gene targeting in the brain for more than 40 genes, as reported to date. For many broadly expressed genes, brain-restricted knockout has overcome lethality of conventional knockout (KO) and has highlighted a specific role of the encoded protein in some aspect of brain function. In the case of neural genes, data from null mutants in specific brain sites or neurons has refined our understanding of the role of individual molecules that regulate complex behaviors or synaptic plasticity within neural circuits. Among the many developing functional genomic approaches, conditional gene targeting in the mouse has become an excellent tool to elucidate the function of the approximately 5000 known or unknown genes that operate in the nervous system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289150     DOI: 10.1016/j.pharmthera.2006.12.003

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  60 in total

Review 1.  Novel approaches to studying the genetic basis of cerebellar development.

Authors:  Samin A Sajan; Kathryn E Waimey; Kathleen J Millen
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

2.  Effects of delta opioid receptors activation on a response inhibition task in rats.

Authors:  Katia Befort; Megan K Mahoney; Carmen Chow; Scott J Hayton; Brigitte L Kieffer; Mary C Olmstead
Journal:  Psychopharmacology (Berl)       Date:  2010-12-23       Impact factor: 4.530

3.  New progenitors NESTIN(g) in the EGL.

Authors:  Ekaterina Pak; Rosalind A Segal; Charles D Stiles
Journal:  Nat Neurosci       Date:  2013-12       Impact factor: 24.884

Review 4.  Unparalleled control of neural activity using orthogonal pharmacogenetics.

Authors:  Mikhail G Shapiro; Shawnalea J Frazier; Henry A Lester
Journal:  ACS Chem Neurosci       Date:  2012-06-01       Impact factor: 4.418

5.  Huntington's disease pattern of transcriptional dysregulation in the absence of mutant huntingtin is produced by knockout of neuronal GLT-1.

Authors:  Robert B Laprairie; Geraldine T Petr; Yan Sun; Kathryn D Fischer; Eileen M Denovan-Wright; Paul A Rosenberg
Journal:  Neurochem Int       Date:  2018-04-27       Impact factor: 3.921

Review 6.  Neuroendocrine consequences of androgen excess in female rodents.

Authors:  Eileen M Foecking; Melissa A McDevitt; Maricedes Acosta-Martínez; Teresa H Horton; Jon E Levine
Journal:  Horm Behav       Date:  2008-01-10       Impact factor: 3.587

Review 7.  DNA strand breaks, neurodegeneration and aging in the brain.

Authors:  Sachin Katyal; Peter J McKinnon
Journal:  Mech Ageing Dev       Date:  2008-03-25       Impact factor: 5.432

Review 8.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

9.  Characterization of transgenic mouse lines expressing Cre recombinase in the retina.

Authors:  E Ivanova; G-S Hwang; Z-H Pan
Journal:  Neuroscience       Date:  2009-10-23       Impact factor: 3.590

Review 10.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.